AveXis to Report Topline Phase 1 Trial Results in SMA Type

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
28
AveXis to Report Topline Phase 1 Trial Results in SMA Type 1 and Fourth Quarter and Full Year 2016 Financial and Operating Results on March 16, 2017

-- Conference call and webcast on March 16 at 4:30 p.m. EDT --

CHICAGO, March 09, 2017 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, will announce topline results from the Phase 1 clinical trial of AVXS-101 in patients with SMA Type 1, and financial and operating results for the fourth quarter and full year ended December 31, 2016 on Thursday, March 16, 2017 after the close of U.S.-based financial markets. AveXis management will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time.

Analysts and investors can participate in the conference call by dialing (844) 889-6863 for domestic callers and (661) 378-9762 for international callers, using the conference ID 84652584. The webcast can be accessed live on the Events and Presentations page in the Investors and Media section of the AveXis website, www.AveXis.com .  The webcast will be archived on the company’s website until its next quarterly earnings call, and will be available for telephonic replay for 14 days following the call by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International), conference ID 84652584.

About SMA SMA is a severe neuromuscular disease characterized by the loss of motor neurons leading to progressive muscle weakness and paralysis. SMA is caused by a genetic defect in the SMN1 gene that codes SMN, a protein necessary for survival of motor neurons. The incidence of SMA is approximately one in 10,000 live births.

The most severe form of SMA is Type 1, a lethal genetic disorder characterized by motor neuron loss and associated muscle deterioration, which results in mortality or the need for permanent ventilation support before the age of two for greater than 90 percent of patients. SMA Type 1 is the leading genetic cause of infant mortality.

About AVXS-101 AVXS-101 is a proprietary gene therapy candidate of a one-time treatment for SMA Type 1 and is currently in development for SMA. AVXS-101 is designed to address the monogenic root cause of SMA and prevent further muscle degeneration by addressing the defective and/or loss of the primary SMN1 gene. AVXS-101 also targets motor neurons providing rapid onset of effect and crosses the blood brain barrier allowing an IV dosing route and effective targeting of both central and systemic features.

About AveXis, Inc. AveXis is a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases. The company’s initial proprietary gene therapy candidate, AVXS-101, is in an ongoing Phase 1 clinical trial for the treatment of SMA Type 1. For additional information, please visit www.avexis.com.

 

Media Inquiries: Lauren Barbiero W2O Group 646-564-2156 lbarbiero@w2ogroup.com Investor Inquiries: Jim Goff AveXis, Inc. 650-862-4134 jgoff@avexis.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 5

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Avive Partners with Cambridge Fire for Lifesaving Training

Updated Category News Views 4

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 8

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 6

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 6

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 4

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 4

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Cabot Wilds: Nova Scotia's Next Luxury Golf Haven

Updated Category News Views 7

Breaking New Ground in Golf and Luxury Cabot and the Bragg family are cooking up something extraordinary in Cumberland County, Nova Scotia. The new luxury lifestyle and golf destination, Cabot Wilds, promises to be more than just a retreat—it's a bold statement on how to marry nature, luxury, and community. Set to open in late 2027, this expansive 2,500-acre resort will...

Continue Reading

Top 5 Most Recently Viewed Articles

Selfii Unveils TripleBlind Exchange for Secure Health Data Sharing

Updated Category News Views 450

Introducing the TripleBlind Exchange by Selfii Selfii, a leader in health data privacy solutions, has announced the launch of its new platform, the TripleBlind Exchange. This revolutionary marketplace provides secure access to protected health information (PHI) while ensuring compliance with HIPAA and GDPR regulations. By utilizing advanced privacy-preserving...

Continue Reading
DarioHealth Partners with Rula to Enhance Mental Health Access

Updated Category News Views 247

Transforming Behavioral Health Services DarioHealth Corp. (Nasdaq: DRIO) has announced an exciting collaboration with Rula Health, a prominent provider of behavioral health services. This strategic partnership significantly boosts the accessibility of mental health support for employers and their employees across the nation. Extensive Provider Network for Improved Access...

Continue Reading
Preparing for Storms: The Importance of Whole-Home Generators

Updated Category News Views 138

Preparing for Storms: The Importance of Whole-Home Generators As storm season approaches, homeowners are encouraged to take proactive steps to safeguard their properties. Quality Heating, Cooling, Plumbing & Electric, a trusted name in HVAC and electrical services, emphasizes the need for installations of whole-home generators. These powerful systems ensure that essential...

Continue Reading
Ibotta Enhances SNAP Rewards for America's Hungry Families

Updated Category News Views 428

Ibotta Steps Up to Support SNAP Participants Ibotta, a prominent player in the digital promotions and performance marketing landscape, has made a significant commitment to supporting millions of Americans through its SNAP Rewards program, benefiting individuals eligible for the Supplemental Nutrition Assistance Program. This initiative highlights Ibotta's dedication to...

Continue Reading
Vallourec Voting Rights and Share Capital Insights

Updated Category News Views 40

Overview of Vallourec and its Share Structure VALLOUREC is a renowned French limited liability company dedicated to providing tubular solutions for the oil and gas industry, among others. Recently, there have been notable updates regarding its voting rights and share capital. As of now, Vallourec has a share capital amounting to €4,761,042.58, reflecting its commitment...

Continue Reading